Shanghai Xinzhi Biomed Co., Ltd.

This is an early-stage study to check the safety of a new one-time gene therapy called BBM-P002 for Parkinson's disease. Doctors will inject the therapy directly into a specific part of the brain in 18 participants who have had Parkinson's for at least 5 years. The main goal is t…

This study is testing a single injection of an experimental gene therapy called BBM-H803 for adults with severe Hemophilia A. The goal is to see if the treatment is safe and if it can help the body produce its own missing clotting factor, which could reduce or prevent bleeding ep…